Home > Healthcare > Medical Devices > Therapeutic Devices > Brachytherapy Devices Market

Brachytherapy Devices Market Size

  • Report ID: GMI6561
  • Published Date: Aug 2023
  • Report Format: PDF

Brachytherapy Devices Market Size

Brachytherapy Devices Market size was valued at USD 716 Million in 2022 and is estimated to account for USD 1.3 billion by 2032.

 

Brachytherapy devices are specialized medical devices used in several cancer disease treatments. Brachytherapy involves placing radioactive sources directly near or within tumors for precise treatment. These devices offer accurate positioning and delivery of radiation while minimizing harm to healthy tissues. Brachytherapy devices enable focused cancer treatment, enhancing effectiveness and reducing side effects. The increasing prevalence of cancer and heightened awareness are some of the major factors driving the demand for advanced treatments such as precise brachytherapy.

 

The escalating incidence rate of cancer globally is a significant driver for the brachytherapy devices market. For instance, according to the 2023 report from the Pan American Health Organization (PAHO), there were approximately 20 million new cancer cases and 10 million cancer-related deaths globally. Moreover, projections suggest that the burden of cancer could increase by about 60% over the next two decades and it is anticipated that the number of new global cancer cases will reach around 30 million by the year 2040.

 

Therefore, as cancer becomes more prevalent, the high demand for effective treatment methods such as brachytherapy will boost revenue growth. Furthermore, public awareness campaigns, education initiatives, and advocacy efforts are contributing to a deeper understanding of cancer, its risks, and available treatment options. Patients are becoming more informed and proactive in making healthcare decisions. Therefore, this heightened awareness also extends to brachytherapy, as patients and healthcare professionals are recognizing its benefits in providing localized treatment while minimizing harm to healthy tissues.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

The global brachytherapy devices industry was valued at USD 716 Million in 2022 and is estimated to account for USD 1.3 billion by 2032.

The low dose rate (LDR) segment size was 78.5% in 2022 and will witness a rapid growth through 2032 attributable to its controlled radiation release and compatibility with personalized medicine.

U.S. brachytherapy devices market accounted for USD 270.5 million in 2022 and is predicted to witness substantial growth through 2032, owing to the increasing geriatric population base along with the rising incidence of cancer in the country.

Merit Medical Systems, Inc., Elekta AB, Isoray Medical, Inc., Becton Dickinson & Company, Eckert & Ziegler BEBIG, CIVCO Medical Solutions, iCAD, Inc., Theragenics Corporation, Siemens AG, IsoAid, Carl Zeiss AG and Argon Medical Devices, Inc. among others.

Brachytherapy Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 420
  • Countries covered: 30
  • Pages: 337
 Download Free Sample